Evidence map›Paper›PMID 40100604›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Mixed Leukocyte Reaction Using Human Plasmacytoid Dendritic Cells and CD4

Sorely Adelina Sosa-Luis, Alexia Almaraz-Arreortua, Honorio Torres-Aguilar

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sorely Adelina Sosa-LuisClinical and Basic Immunology Research Department of Biochemical Sciences Faculty, Universidad Autónoma "Benito Juárez" de Oaxaca, Oaxaca, Mexico.
Alexia Almaraz-ArreortuaClinical and Basic Immunology Research Department of Biochemical Sciences Faculty, Universidad Autónoma "Benito Juárez" de Oaxaca, Oaxaca, Mexico.
Honorio Torres-AguilarClinical and Basic Immunology Research Department of Biochemical Sciences Faculty, Universidad Autónoma "Benito Juárez" de Oaxaca, Oaxaca, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasmacytoid dendritic cells (pDCs) are critical in antiviral immune responses and play a significant role in developing autoimmune diseases and transplant rejection. Despite their scarcity in peripheral blood, the accessibility of blood peripheral pDCs makes them a promising source for evaluating T-cell antigen-specific responses in viral infections and autoimmune diseases, as well as alloreactive stimulation in transplantation, including graft-versus-host disease. T-cell priming assays with pDCs have presented a significant challenge due to the low proliferation of T cells. This underscores the critical need for meticulous standardization of suitable conditions for cell purification and coculture in peripheral blood pDC-based mixed leukocyte reactions (MLRs) to ensure productive and quantitative results. This chapter presents a thorough methodology for isolating peripheral blood human pDCs and their application in an MLR assay to evaluate alloreactive T-cell responses using flow cytometry and the adjustments to analyze antigen-specific reactions.

Indexed as

CD4-Positive T-LymphocytesDendritic CellsCell SeparationCoculture TechniquesFlow CytometryHumansLymphocyte ActivationLymphocyte Culture Test, MixedAntigen-presenting cellsAutoimmunityDendritic cellsFlow cytometryMixed leukocyte reactionsPeripheral blood plasmacytoid dendritic cellsT-cell alloreactivityT cellsTransplant rejectionViral infections

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.